120 related articles for article (PubMed ID: 2439786)
1. Effect of bisoprolol on exercise tolerance in patients with coronary heart disease: placebo-controlled double-blind crossover study.
Schnellbacher K; Marsovszky E; Roskamm H
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S143-7. PubMed ID: 2439786
[TBL] [Abstract][Full Text] [Related]
2. Effect of bisoprolol on cardiac performance in coronary heart disease.
Maisch B; Borst U; Gerhards W; Wagner G
Eur J Clin Pharmacol; 1989; 36(3):217-22. PubMed ID: 2568261
[TBL] [Abstract][Full Text] [Related]
3. [Effect of bisoprolol in coronary heart disease. Effect on cardiovascular parameters and ischemic ST depression: studies on the duration of the effect].
Prager G; Wagner G
Dtsch Med Wochenschr; 1984 Dec; 109(50):1914-7. PubMed ID: 6150839
[TBL] [Abstract][Full Text] [Related]
4. Haemodynamic effects of bisoprolol in patients with coronary heart disease: influence of various bisoprolol plasma concentrations.
Bonelli J; Staribacher H
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S83-6. PubMed ID: 2439805
[TBL] [Abstract][Full Text] [Related]
5. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
Kohli RS; Khurmi NS; Kardash MM; Hughes LO; Lahiri A; Raftery EB
Eur Heart J; 1985 Oct; 6(10):845-50. PubMed ID: 2866960
[TBL] [Abstract][Full Text] [Related]
7. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris.
de Muinck E; Wagner G; vd Ven LL; Lie KI
Eur Heart J; 1987 Dec; 8 Suppl M():31-5. PubMed ID: 2897300
[TBL] [Abstract][Full Text] [Related]
10. Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
Kohli RS; Lahiri A; Raftery EB
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S148-53. PubMed ID: 2439787
[TBL] [Abstract][Full Text] [Related]
11. Summary of short- and long-term studies with bisoprolol in coronary heart disease (CHD).
Wagner G
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S160-6. PubMed ID: 2439790
[TBL] [Abstract][Full Text] [Related]
12. Effects of bisoprolol in relation to metoprolol and bufuralol on left ventricular hemodynamics at rest and during exercise in chronic ischemic heart disease.
Burkart F; Pfisterer M; Steinmann E
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S78-82. PubMed ID: 2439804
[TBL] [Abstract][Full Text] [Related]
13. Dose-response relationship of the beta-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis.
Dorow P; Tönnesmann U
Eur J Clin Pharmacol; 1984; 27(2):135-9. PubMed ID: 6149938
[TBL] [Abstract][Full Text] [Related]
14. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
Dorow P; Bethge H; Tönnesmann U
Eur J Clin Pharmacol; 1986; 31(2):143-7. PubMed ID: 2879733
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of carvedilol in exercise-induced myocardial ischemia.
Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S137-40. PubMed ID: 2454360
[TBL] [Abstract][Full Text] [Related]
16. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B
Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874
[TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
[TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic effects of bisoprolol, a new beta 1 selective adrenoreceptor blocking agent, in patients with coronary artery disease.
Steinmann E; Pfisterer M; Burkart F
J Cardiovasc Pharmacol; 1986; 8(5):1044-50. PubMed ID: 2429078
[TBL] [Abstract][Full Text] [Related]
19. Beta 1/beta 2-splitting of bisoprolol.
Dorow P
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S65-8. PubMed ID: 2439801
[TBL] [Abstract][Full Text] [Related]
20. Anti-ischemic effects of celiprolol in patients with exercise-induced angina pectoris.
Douard H; Koch M; Laporte T; Abella ML; Provendier O; Broustet JP
Int J Cardiol; 1989 Oct; 25(1):63-8. PubMed ID: 2571590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
